Another case of reversibility of visual-field defect induced by vigabatrin monotherapy: is young age a favorable factor?
Giordano
L
L
Valseriati
D
D
Vignoli
A
A
Morescalchi
F
F
Gandolfo
E
E
D000293:Adolescent; D000927:Anticonvulsants / Q000009:adverse effects*; D004828:Epilepsies, Partial / Q000188:drug therapy*; D005260:Female; D006801:Humans; D020888:Vigabatrin / Q000009:adverse effects*; D014786:Vision Disorders / Q000139:chemically induced*; D014794:Visual Fields / Q000187:drug effects*
D000927:Anticonvulsants; D020888:Vigabatrin